ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Spatial specific delivery of combinational chemotherapeutics to combat intratumoral heterogeneity

Wang, Kewei; Jiang, Maolin; Zhou, Jielian; Dong, Yansong; Liu, Ye; Zong, Qingyu; Sandbhor, Puja; Singh, N. D. Pradeep; Yuan, Youyong*
Journal of Controlled Release2022-8DOI: 10.1016/j.jconrel.2022.06.046
5被引8阅读
引用收藏
分享

摘要

Hypoxia-induced intratumoral heterogeneity poses a major challenge in tumor therapy due to the varying susceptibility to chemotherapy. Moreover, the spatial distribution patterns of hypoxic and normoxic tissues makes conventional combination therapy less effective. In this study, a tumor-acidity and bioorthogonal chemistry mediated in situ size transformable nanocarrier (NP@DOXDBCO plus iCPPAN3) was developed to spatially deliver two combinational chemotherapeutic drugs (doxorubicin (DOX) and PR104A) to combat hypoxia-induced intratumoral heterogeneity. DOX is highly toxic to tumor cells in normoxia state but less toxic in hypoxia state due to the hypoxia-induced chemoresistance. Meanwhile, PR104A is a hypoxia-activated prodrug has less toxic in normoxia state. Two nanocarriers, NP@DOXDBCO and iCPPAN3, can cross-link near the blood vessel extravasation sites through tumor acidity responsive bioorthogonal click chemistry to enhance the retention of DOX in tumor normoxia. Moreover, PR104A conjugated to the small-sized dendritic polyamidoamine (PAMAM) released under tumor acidity can penetrate deep tumor tissues for hypoxic tumor cell killing. Our study has demonstrated that this site-specific combination chemotherapy is better than the traditional combination chemotherapy. Therefore, spatial specific delivery of combinational therapeutics via in situ size transformable nanocarrier addresses the challenges of hypoxia induced intratumoral heterogeneity and provides insights into the combination therapy.

学科与关键词

关键词
Bioorthogonal chemistrySize transformable nanocarrierIntratumoral heterogeneityCombination chemotherapyTumor hypoxia
相关
加载中…
  • Perivascular nanocarrier aggregation as a drug reservoir augments tumor drug delivery and treatment efficacy
    Dong, Yansong; Tu, Yalan; Liu, Ye; Jiang, Maolin; Bulatov, Emil; Yuan, Youyong*; Wang, Jun*Nano Today, 2023, 53: 102004.
  • Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy
    Wang, Kewei; Jiang, Maolin; Zhou, Jielian; Liu, Ye; Zong, Qingyu; Yuan, Youyong*ACS Nano, 2022, 16(1): 721-735.被引 46
  • Bioorthogonal chemistry and illumination controlled programmed size-changeable nanomedicine for synergistic photodynamic and hypoxia-activated therapy
    Jiang, Maolin; Liu, Ye; Dong, Yansong; Wang, Kewei; Yuan, Youyong*Biomaterials, 2022, 284: 121480.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Controlled Release
发表日期
2022-08
卷期
第 348 卷
页码
1004-1015
DOI
10.1016/j.jconrel.2022.06.046
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [51873072, 52073101]; Science and Technology Program of Guangzhou [202102010025]; Guangdong Provincial Pearl River Talents Program [2019QN01Y088]; Special Fund for the Construction of High-level Key Clinical Specialty (Medical Imaging) in Guangzhou; Guangzhou Key Laboratory of Molecular Imaging and Clinical Translational Medicine; Guangdong Basic and Applied Basic Research Foundation [2021A1515110258]; Open Fund of Key Laboratory of Biomaterials of Guangdong Higher Education Institutes; Guangdong Provincial Engineering and Technological Research Center for Drug Carrier Development

作者

  • W

    Wang, Kewei (第一作者)

  • J

    Jiang, Maolin

查看全部 9 位作者收起作者
  • Z

    Zhou, Jielian

  • D

    Dong, Yansong

  • L

    Liu, Ye

  • Z

    Zong, Qingyu

  • S

    Sandbhor, Puja

  • S

    Singh, N. D. Pradeep

  • Y

    Yuan, Youyong (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417